DCGI calls for strict reporting of side-effects related to medical devices

In its circular issued this week the top drug regulator said that the post-market surveillance of medical devices is important to ensure safety and performance

Published - May 18, 2024 02:31 am IST - NEW DELHI

The Drugs Controller General of India (DCGI) has called for timely reporting of adverse events related to medical devices and directed all medical device licence holders and manufacturers to report any adverse events related to life-saving medical equipment on the government’s Materiovigilance Programme of India (MvPI) platform stating that the move is vital to mitigate risks and safeguard public health.

In its circular issued this week the top drug regulator said that the post-market surveillance (PMS) of medical devices is one of the important aspects to ensure safety and performance of the medical devices.

“PMS supports identifying and addressing any potential risk or adverse event associated with the medical device. Timely reporting of the adverse events allows for the identification of unidentifiable risks, analysing frequency of already identified risks and enabling the manufacturers and regulatory authorities to take appropriate measures to mitigate risks and safeguard public health,” it said.

The MvPI was launched by the Health Ministry with the objective to improve Indian patient safety by monitoring, recording and analysing the root cause of adverse events or risks associated with the use of medical devices including in-vitro diagnostics by healthcare professionals or patients/users and suggesting regulatory bodies for appropriate action with the sole intention of improving patient safety.

“Mvpl is an important program for reporting of adverse events, coordinated analysis etc related to the medical devices including in-vitro diagnostic devices, therefore it is suggested that all the license holder should also use the MvPI platform for reporting of any adverse events/serious adverse events associated with the devices,” the communication said.

Currently in India medical devices including In-vitro diagnostic medical devices have come under the regulation under the Drugs and Cosmetics Act, 1940 and Medical Devices Rules, 2017. A license/approval is required for the import/manufacture for marketing of the devices in the country. 

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.